Larvol Delta - Phase-1-study-of-LB1410-a-bivalent-TIM3PD1-bispecific-antibody-in-patients-with-advanced-solid-tumors

Bis2 - L&L Biopharma

LB1410 - L&L Biopharma

http://clinicaltrials.gov/ct2/show/NCT06468358

Jun 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next